Val Gebski - Concepedia

Author

Val Gebski

Also Known As

A Dobrovic, A S Coates, Andrew Strickland, G. C. Toner, Gebski, V., Gebski, Val, Gebski, Val J., H Dhillon, Hammond, I, Howard Chan

746

Publications

35.1K

Citations

H-Index

266

Concepts

All Affiliations

The University of Sydney National Health and Medical Research Council Westmead Hospital The University of Queensland Peter MacCallum Cancer Centre

About

Val Gebski is an author at The University of Sydney specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Health Sciences	23	44	2K
2	Engineering	8	8	611
3	Education	3	3	252
4	Management	2	2	78
5	Language Studies	1	1	11

Val Gebski

279

Publications

24.9K

Citations

H-Index

Page 1

	Year	Citations
Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial Éric Pujade-Lauraine, Jonathan A. Ledermann, Frédèric Selle, The Lancet Oncology Brca1/2 MutationMedicineCancer ManagementGynecologyOlaparib Tablets	2017	1.8K
Minimally Invasive versus Abdominal Radical Hysterectomy for Cervical Cancer Pedro T. Ramírez, Michael Frumovitz, René Pareja, New England Journal of Medicine	2018	1.8K
Effect of Laparoscopic-Assisted Resection vs Open Resection on Pathological Outcomes in Rectal Cancer Andrew R. L. Stevenson, Michael J. Solomon, John W. Lumley, JAMA	2015	998
Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial Bryan Burmeister, B. Mark Smithers, Val Gebski, The Lancet Oncology Surgical OncologyResectable CancerEsophagusGastrointestinal OncologyEsophageal Cancer	2005	928
SIRveNIB: Selective Internal Radiation Therapy Versus Sorafenib in Asia-Pacific Patients With Hepatocellular Carcinoma Pierce K. H. Chow, Mihir Gandhi, Say-Beng Tan, Journal of Clinical Oncology	2018	625
Pegylated Liposomal Doxorubicin and Carboplatin Compared With Paclitaxel and Carboplatin for Patients With Platinum-Sensitive Ovarian Cancer in Late Relapse Éric Pujade-Lauraine, Uwe Wagner, Elisabeth Aavall-Lundqvist, Journal of Clinical Oncology	2010	558
Improving the Quality of Life during Chemotherapy for Advanced Breast Cancer Alan S. Coates, Val Gebski, James F. Bishop, New England Journal of Medicine	1987	538
Randomised trial of SIR-Spheres® plus chemotherapy vs. chemotherapy alone for treating patients with liver metastases from primary large bowel cancer Bruce N. Gray, Guy van Hazel, MD Thomas A. Hope, Annals of Oncology Surgical OncologyGastrointestinal OncologyMedicineHepatobiliary TumorGastroenterology	2001	522
Effect of a Monoclonal Antibody to PCSK9 on Low-Density Lipoprotein Cholesterol Levels in Statin-Intolerant Patients David Sullivan, Anders Olsson, Robert C. Scott, JAMA	2012	445
Capecitabine, Bevacizumab, and Mitomycin in First-Line Treatment of Metastatic Colorectal Cancer: Results of the Australasian Gastrointestinal Trials Group Randomized Phase III MAX Study Niall C. Tebbutt, Kate Wilson, Val Gebski, Journal of Clinical Oncology	2010	412

Page 1